<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[General Medicine and Specialty Medicine Industry in China: Market Research Reports, Statistics and Analysis]]></title>
    <link>http://www.reportlinker.com/ci02244/General-Medicine-and-Specialty-Medicine.html/coverage/Asia:China</link>
    <description><![CDATA[Reportlinker.com Lastest General Medicine and Specialty Medicine Industry in China: Market Research Reports, Statistics and Analysis]]></description>
    <pubDate>Fri, 24 May 2013 06:24:50 +0000</pubDate>
    <webMaster>helpdesk@reportlinker.com</webMaster>
    <copyright>Copyright 2013, Reportlinker</copyright>
    <generator>Zend_Feed</generator>
    <language>en-us</language>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Company Report: General Medicine and Specialty Medicine in China for Year 2011]]></title>
      <link>http://www.reportlinker.com/d013262191/Company-Report-General-Medicine-and-Specialty-Medicine-in-China-for-Year-2011.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013262191/Company-Report-General-Medicine-and-Specialty-Medicine-in-China-for-Year-2011.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Will be payable if the insured, after a hospital confinement whereby a daily hospital income benefit is payable, dies as a result (directly and  independently of all other causes) of the negligence of a <strong>medical</strong> ...]]></description>
      <pubDate>Wed, 30 Nov 2011 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: General Medicine and Specialty Medicine in China for Year 2011]]></title>
      <link>http://www.reportlinker.com/d013592215/Company-Report-General-Medicine-and-Specialty-Medicine-in-China-for-Year-2011.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013592215/Company-Report-General-Medicine-and-Specialty-Medicine-in-China-for-Year-2011.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Is a revenue-generating, profitable, specialty pharmaceutical company with a substantial commercial  business in china and a product portfolio of therapies for oncology, <strong>infectious</strong> <strong>diseases</strong> and cardiovascular ...]]></description>
      <pubDate>Wed, 30 Nov 2011 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: General Medicine and Specialty Medicine in China for Year 2011]]></title>
      <link>http://www.reportlinker.com/d013049441/Company-Report-General-Medicine-and-Specialty-Medicine-in-China-for-Year-2011.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013049441/Company-Report-General-Medicine-and-Specialty-Medicine-in-China-for-Year-2011.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ]]></description>
      <pubDate>Wed, 30 Nov 2011 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[SciClone Pharmaceuticals Inc. - Company Report for Year 2011]]></title>
      <link>http://www.reportlinker.com/d014196659/SciClone-Pharmaceuticals-Inc-Company-Report-for-Year-2011.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014196659/SciClone-Pharmaceuticals-Inc-Company-Report-for-Year-2011.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... About sciclone  sciclone pharmaceuticals is a us-based, china-focused specialty pharmaceutical company with a product portfolio of  therapies for oncology, <strong>infectious</strong> <strong>diseases</strong> and cardiovascular ...]]></description>
      <pubDate>Wed, 30 Nov 2011 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Walden Group - Company Report for Year 2012]]></title>
      <link>http://www.reportlinker.com/d012992155/Walden-Group-Company-Report-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012992155/Walden-Group-Company-Report-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ]]></description>
      <pubDate>Wed, 29 Feb 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[SciClone Pharmaceuticals Inc. - Company Report for Year 2012]]></title>
      <link>http://www.reportlinker.com/d013139226/SciClone-Pharmaceuticals-Inc-Company-Report-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013139226/SciClone-Pharmaceuticals-Inc-Company-Report-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Business in china and a product portfolio of therapies for oncology, <strong>infectious</strong> <strong>diseases</strong> and cardiovascular, urological,  respiratory, and central nervous system disorders. Sciclone's zadaxin   (thymalfasin ...]]></description>
      <pubDate>Mon, 30 Apr 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: General Medicine and Specialty Medicine in China for Year 2012]]></title>
      <link>http://www.reportlinker.com/d013240587/Company-Report-General-Medicine-and-Specialty-Medicine-in-China-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013240587/Company-Report-General-Medicine-and-Specialty-Medicine-in-China-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Oxygenators, also named as artificial lung, are for the use in extra-corporal on-pump <strong>cardiac</strong>  <strong>surgery</strong>, with the function of oxygenating the non-oxygenated blood into oxygenated blood.  According ...]]></description>
      <pubDate>Thu, 31 May 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Eye Care in India, China and Japan for Year 2012]]></title>
      <link>http://www.reportlinker.com/d013578028/Company-Report-Eye-Care-in-India-China-and-Japan-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013578028/Company-Report-Eye-Care-in-India-China-and-Japan-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... <Strong>eye</strong> <strong>care</strong>  * as of june 27, 2012, we have changed our  organizational structure to three in-house  companies. As a result, the former <strong>eye</strong> <strong>care</strong>  business unit became the <strong>eye</strong> <strong>care</strong> company. The vision ...]]></description>
      <pubDate>Thu, 31 May 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: General Medicine and Specialty Medicine in China for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014174148/Company-Report-General-Medicine-and-Specialty-Medicine-in-China-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014174148/Company-Report-General-Medicine-and-Specialty-Medicine-in-China-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Identified infants with permanent hearing loss at 12 to 16 months of age. <Strong>pediatrics</strong> 122:535 544. 37. Puig t, municio a, meda  C (2005) universal neonatal hearing screening versus selective screening as part ...]]></description>
      <pubDate>Mon, 31 Dec 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[General Medicine and Specialty Medicine Sector in China]]></title>
      <link>http://www.reportlinker.com/d013633580/General-Medicine-and-Specialty-Medicine-Sector-in-China.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013633580/General-Medicine-and-Specialty-Medicine-Sector-in-China.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Cardiology product, as well as  several of its <strong>oncology</strong> products exclusively promoted in china for pfizer and baxter were reduced at or below the average  price reduction announced by the government ...]]></description>
      <pubDate>Fri, 31 Aug 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Eye Care in Hong Kong, China]]></title>
      <link>http://www.reportlinker.com/p0846360/Eye-Care-in-Hong-Kong-China.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0846360/Eye-Care-in-Hong-Kong-China.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/119.gif"> In 2012, higher air pollution and uncomfortable eyes, driven by wearing contact lenses and using computers for a long daily time without sufficient eye rest, led to a positive value growth in sales. Hence, ...]]></description>
      <pubDate>Thu, 16 May 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Eye Care in China]]></title>
      <link>http://www.reportlinker.com/p01159796/Eye-Care-in-China.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01159796/Eye-Care-in-China.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/119.gif"> Eye care continued its robust growth in both value and volume terms in China in 2012, thanks to growing consumer awareness and the effects of faster pace of life. According to China Internet Network Information ...]]></description>
      <pubDate>Wed, 03 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[VEPRO AG SWOT Analysis, Strategy, Revenues and Profits]]></title>
      <link>http://www.reportlinker.com/p0425393/VEPRO-AG-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0425393/VEPRO-AG-Strategic-SWOT-Analysis-Review.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...]]></description>
      <pubDate>Thu, 07 Mar 2013 23:00:00 +0000</pubDate>
    </item>
  </channel>
</rss>
